糖肾康治疗糖尿病肾病的临床与实验研究(Clinical and experimental study on diabetic nephropathy treated with Shen Shen Kang).docVIP

  • 3
  • 0
  • 约8.37千字
  • 约 8页
  • 2017-09-15 发布于河南
  • 举报

糖肾康治疗糖尿病肾病的临床与实验研究(Clinical and experimental study on diabetic nephropathy treated with Shen Shen Kang).doc

糖肾康治疗糖尿病肾病的临床与实验研究(Clinical and experimental study on diabetic nephropathy treated with Shen Shen Kang)

糖肾康治疗糖尿病肾病的临床与实验研究(Clinical and experimental study on diabetic nephropathy treated with Shen Shen Kang) Clinical and experimental study on diabetic nephropathy treated with Shen Shen Kang Update Date: 2009-04-24 click: Tong Jie Shi Hong Cao Gang Objective: To evaluate the therapeutic effect of diabetic nephropathy treated by Shen Shen Kang capsule. Methods: 300 patients with diabetic nephropathy were randomly divided into 200 groups, and 100 cases were treated with Kato Pury capsule. Results compared with the control group, the effective rate of the capsule was significantly different (P 0.05). The results of animal experiments showed that Tangshenkang capsule has the hypoglycemic effect on diabetic rabbits; can significantly improve the glucose tolerance in rats; reduce the effect on proteinuria in nephrotic rats; Tangshenkang capsule high dose absorption with no obvious side effect. Conclusion: the Chinese herbal medicine Kang Shen Kang Capsule has a good effect in relieving symptoms, reducing urinary protein and stabilizing blood sugar. Keywords sugar kidney capsule; diabetic nephropathy; urine protein; blood sugar; CLC number: R 289.5, document identifier code: A Article number: 1007-5615 (2000) 03-0005-04 Diabetic nephropathy (DN) is one of the three leading causes of diabetes death. Chinese medicine treatment of this disease reported many, the effective rate is between 60% and 70%. In combination with the clinical practice, the treatment of this disease from the liver, with the principle of soothing the liver and regulating qi and invigorating the kidney and promoting blood circulation, the effective rate of the clinical treatment was 90%, and the pharmacodynamics test was carried out. The result is as follows. 1 clinical observation 1.1 clinical data 300 patients all according to WHO diagnostic criteria [1] diagnosed diabetes, and use Gao Yanbins diabetic nephropathy diagnostic staging criteria [2]. All cases excluded renal insufficiency caused by cardiac in

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档